Evaluation of Geistlich Fibro-Gide ® and Autogenous Connective Tissue Graft Prior to Orthodontic Maxillary Expansion.

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 1, 2022

Primary Completion Date

January 23, 2024

Study Completion Date

January 23, 2024

Conditions
Thin GingivaTransverse Maxillary DeficiencyCross Bite
Interventions
PROCEDURE

Gingival Phenotype Modification

Autogenous Connective Tissue Graft is the current gold standard for soft tissue phenotype modification. This is being compared with a substitute material called Geistlich Fibro-Gide ® for soft tissue phenotype modification before orthodontic treatment. Geistlich Fibro-Gide ® is a porcine, porous, resorbable and volume-stable collagen matrix, designed for soft-tissue regeneration. Surgical flap design will be an envelope for both interventions.

Trial Locations (1)

T6G 2H5

University of Alberta, Kaye Edmonton Clinic, Edmonton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Geistlich Pharma AG

INDUSTRY

lead

University of Alberta

OTHER

NCT05295771 - Evaluation of Geistlich Fibro-Gide ® and Autogenous Connective Tissue Graft Prior to Orthodontic Maxillary Expansion. | Biotech Hunter | Biotech Hunter